Paper Details
- Home
- Paper Details
Original Abstract of the Article :
From October, 1993 to August, 1994, a post-marketing surveillance study enrolled 9,568 adults and children treated for respiratory tract infections with cefixime in a daily dose of 400 mg or 8 mg/kg body weight, respectively. Twice daily dosage was preferred with adults (60.4%) and children (54.4%)....See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1007/BF01742986
データ提供：米国国立医学図書館（NLM）
Cefixime: A Reliable Oasis in the Desert of Respiratory Tract Infections
Respiratory tract infections are a common and often debilitating ailment, and finding effective and safe treatment options is crucial for patient well-being. This post-marketing surveillance study investigates the safety and efficacy of cefixime, an oral antibiotic, in treating respiratory tract infections in a large cohort of German adults and children. The study, which involved 9,568 patients, found that cefixime was highly effective in treating a wide range of respiratory tract infections, including bronchitis and otitis media. The study observed a high cure or improvement rate (98.7% for adults and 98.0% for children), with rapid symptom improvement in most cases. Furthermore, the study reported a low incidence of adverse events, making cefixime a safe and well-tolerated treatment option. These findings suggest that cefixime is a valuable and reliable treatment option for respiratory tract infections, offering a promising solution for managing these common ailments.
Cefixime: A Reliable Solution for Respiratory Infections
The study's findings demonstrate the high efficacy and safety of cefixime in treating respiratory tract infections, offering a valuable tool for managing these common ailments. The study's large sample size and comprehensive data collection contribute to its robustness and reliability.
Navigating the Desert of Respiratory Illness: Choosing the Right Treatment
Respiratory tract infections can be frustrating and disruptive to daily life. This research highlights the importance of choosing effective and safe treatment options for these common illnesses. Cefixime emerges as a promising solution, offering a reliable and well-tolerated approach to managing respiratory infections.
Dr.Camel's Conclusion
The desert of respiratory illness can be a challenging landscape to navigate. This research provides a reassuring oasis, demonstrating the effectiveness and safety of cefixime as a valuable treatment option for managing respiratory tract infections.
Date :
- Date Completed 1996-02-08
- Date Revised 2019-08-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.